Parenteral Nutrition Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Adult Patients Requiring Long-term Parenteral Nutrition
Condition: Manganese Safety in Adults Interventions: Drug: Tralement; Drug: Fixed-dose trace element combination product of zinc, copper, and selenious acid Sponsor: American Regent, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2022 Category: Research Source Type: clinical trials